2024
Complex Congenital Heart Disease in the Adult
Goldstein S, Krasuski R. Complex Congenital Heart Disease in the Adult. Annual Review Of Medicine 2024, 75: 493-512. PMID: 38285514, DOI: 10.1146/annurev-med-050922-052324.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCongenital heart diseaseAdult congenital heart diseaseComplex congenital heart diseaseHeart diseaseSevere birth defectsStructural abnormalitiesBirth defectsComplex lesionsFrequent causeHigh riskImprove outcomesPediatric outcomesHeterogeneous groupPalliative interventionsCardiovascular systemDiseaseAdultsOutcomesComplications426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease
Denoble A, Federspiel J, Goldstein S, Culhane J, Dysart K. 426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease. American Journal Of Obstetrics And Gynecology 2024, 230: s235-s236. DOI: 10.1016/j.ajog.2023.11.452.Peer-Reviewed Original Research
2022
Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery Hospitalizations
Denoble A, Goldstein S, Wein L, Grotegut C, Federspiel J. Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery Hospitalizations. JACC Advances 2022, 1: 100157. PMID: 36684662, PMCID: PMC9851052, DOI: 10.1016/j.jacadv.2022.100157.Peer-Reviewed Original ResearchSevere maternal morbidityIschemic heart diseaseDelivery hospitalizationsComplex survey methodsCardiac diseaseCardiac diagnosisMaternal morbidityHeart diseasePre-existing ischaemic heart diseasePre-existing ischemic heart diseaseNontransfusion severe maternal morbidityWorld Health Organization classificationClass IAdverse pregnancy outcomesNationwide Readmissions DatabaseRelative risk regressionWorld Health Organization class IPregnancy outcomesPrimary outcomeRetrospective studyAdverse outcomesUnadjusted analysesOrganization classificationRisk regressionWorse outcomesPulmonary Hypertension in Adults with Congenital Heart Disease
Goldstein S, Krasuski R. Pulmonary Hypertension in Adults with Congenital Heart Disease. Cardiology Clinics 2022, 40: 55-67. PMID: 34809917, DOI: 10.1016/j.ccl.2021.08.006.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPAH-CHDPulmonary arterial hypertension related to congenital heart diseaseSystemic-to-pulmonary shuntAssociated with significant morbidityCongenital heart diseasePulmonary vascular resistancePulmonary vascular remodelingShunt reversalEisenmenger syndromePulmonary hypertensionCentral cyanosisPrimary management strategySignificant morbidityMedical therapySevere elevationVascular resistanceDefect closureSevere phenotypeVascular remodelingHeart diseasePathological processesShuntCyanosisAdultsHypoxemiaImpact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizations
Denoble A, Goldstein S, Grotegut C, Federspiel J. Impact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizations. American Journal Of Obstetrics And Gynecology 2022, 226: s77. DOI: 10.1016/j.ajog.2021.11.146.Peer-Reviewed Original Research
2021
AGE AND LOCATION OF DEATH DIFFER IN ADULT PATIENTS WITH CONGENITAL HEART DISEASE COMPARED WITH THE GENERAL POPULATION
Goldstein S, Kumar P, Shahid I, Serfas J, Krasuski M, Khan M, Krasuski R. AGE AND LOCATION OF DEATH DIFFER IN ADULT PATIENTS WITH CONGENITAL HEART DISEASE COMPARED WITH THE GENERAL POPULATION. Journal Of The American College Of Cardiology 2021, 77: 489. DOI: 10.1016/s0735-1097(21)01848-9.Peer-Reviewed Original Research
2020
Causes of Death and Cardiovascular Comorbidities in Adults With Congenital Heart Disease
Goldstein S, D’Ottavio A, Spears T, Chiswell K, Hartman R, Krasuski R, Kemper A, Meyer R, Hoffman T, Walsh M, Sang C, Paolillo J, Li J. Causes of Death and Cardiovascular Comorbidities in Adults With Congenital Heart Disease. Journal Of The American Heart Association 2020, 9: e016400. PMID: 32654582, PMCID: PMC7660712, DOI: 10.1161/jaha.119.016400.Peer-Reviewed Original ResearchConceptsCongenital heart diseaseSevere congenital heart diseaseMedian ageNonsevere CHDPresence of cardiovascular comorbiditiesHeart diseaseCardiovascular risk factorsNon-CHD causesIschemic heart diseaseElectronic medical record dataDeath certificate dataCause of deathNonsevere diseaseContemporary cohortValvular lesionsCardiovascular comorbidityCardiovascular comorbiditiesResults PatientsCardiovascular deathMedical record dataRisk factorsSevere groupLesion severityPatientsCertificate data
2017
The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes
Goldstein S, Ward C, Al-Khatib S. The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes. Journal Of Innovations In Cardiac Rhythm Management 2017, 9: 2996-3005. PMID: 32494470, PMCID: PMC7252881, DOI: 10.19102/icrm.2018.090103.Peer-Reviewed Original ResearchCongenital heart diseaseInherited arrhythmia syndromesSudden cardiac deathArrhythmia syndromesCardiac deathIncreased risk of sudden cardiac deathPrevention of sudden cardiac deathRisk of sudden cardiac deathHeart diseaseImplantable cardioverter-defibrillator (ICDCardioverter-defibrillator (ICDRisk stratification methodsNon-randomized studiesImplantable cardioverter-defibrillatorRandomized clinical trialsCardioverter-defibrillatorClinical trialsIncreased riskPatientsSyndromeDiseaseImplantationStratification methodICDDeathCongenital and Acquired Valvular Heart Disease in Pregnancy
Goldstein S, Ward C. Congenital and Acquired Valvular Heart Disease in Pregnancy. Current Cardiology Reports 2017, 19: 96. PMID: 28840470, DOI: 10.1007/s11886-017-0910-6.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsValvular heart diseaseHeart diseaseRisk of pregnancy-related complicationsManagement of valvular heart diseaseWomen of childbearing agePregnancy-related complicationsAcquired valvular heart diseaseRheumatic heart diseaseValvular abnormalitiesCongenital abnormalitiesCase reportSymptomatic diseaseChildbearing ageRegurgitant lesionsHemodynamic effectsPatient populationPregnancyPercutaneous interventionStenotic lesionsRefractory symptomsHigh riskObservational studyReviewThe numberDiseaseAbnormalities